Hernando Vargas-Uricoechea1, Luz Ángela Casas-Figueroa2. 1. Division of Endocrinology and Metabolism, Internal Medicine Department, Universidad del Cauca, Popayán-Cauca, Colombia. 2. Division of Endocrinology, Fundación Clínica Valle de Lili and CES University and ICESI University, Cali-Valle, Colombia. Electronic address: luzangelacasas@hotmail.com.
Abstract
BACKGROUND: The burden of diabetes is a global problem, wherein the significant growth of diabetes in Colombia reflects a complex pathophysiology and epidemiology found in many other South American nations. OBJECTIVES: The aim of this study was to analyze epidemiologic data from Colombia and the South American region in general to identify certain disease drivers and target them for intervention to curb the increasing prevalence of diabetes. METHODS: A detailed search was conducted using MEDLINE, SciELO, HINARI, LILACS, IMBIOMED, and Latindex databases, in addition to clinical practice guidelines, books, manuals, and other files containing relevant and verified information on diabetes in Colombia. FINDINGS: According to the International Diabetes Federation and the World Health Organization, the prevalence of diabetes in Colombia is 7.1% and 8.5%, respectively. In contrast, a national survey in Colombia shows a prevalence ranging from 1.84% to 11.2%, depending on how the diagnosis is made, the criteria used, and the age range studied. The prevalence exclusively in rural areas ranges from 1.4% to 7.9% and in urban areas from 1% to 46%. The estimated mean overall (direct and indirect) cost attributed to type 2 diabetes is 5.7 billion Colombian pesos (US $2.7 million). Diabetes is the fifth leading cause of death in Colombia with a rate of 15 deaths per 100,000 individuals. CONCLUSIONS: Based on a clustering of factors, 4 relevant disease drivers emerge that may account for the epidemiology of diabetes in Colombia: demographic transition, nutritional transition, forced displacement/internal migration and urban development, and promotion of physical activity.
BACKGROUND: The burden of diabetes is a global problem, wherein the significant growth of diabetes in Colombia reflects a complex pathophysiology and epidemiology found in many other South American nations. OBJECTIVES: The aim of this study was to analyze epidemiologic data from Colombia and the South American region in general to identify certain disease drivers and target them for intervention to curb the increasing prevalence of diabetes. METHODS: A detailed search was conducted using MEDLINE, SciELO, HINARI, LILACS, IMBIOMED, and Latindex databases, in addition to clinical practice guidelines, books, manuals, and other files containing relevant and verified information on diabetes in Colombia. FINDINGS: According to the International Diabetes Federation and the World Health Organization, the prevalence of diabetes in Colombia is 7.1% and 8.5%, respectively. In contrast, a national survey in Colombia shows a prevalence ranging from 1.84% to 11.2%, depending on how the diagnosis is made, the criteria used, and the age range studied. The prevalence exclusively in rural areas ranges from 1.4% to 7.9% and in urban areas from 1% to 46%. The estimated mean overall (direct and indirect) cost attributed to type 2 diabetes is 5.7 billion Colombian pesos (US $2.7 million). Diabetes is the fifth leading cause of death in Colombia with a rate of 15 deaths per 100,000 individuals. CONCLUSIONS: Based on a clustering of factors, 4 relevant disease drivers emerge that may account for the epidemiology of diabetes in Colombia: demographic transition, nutritional transition, forced displacement/internal migration and urban development, and promotion of physical activity.
Authors: Mary McEniry; Rafael Samper-Ternent; Carmen Elisa Flórez; Renata Pardo; Carlos Cano-Gutierrez Journal: J Gerontol B Psychol Sci Soc Sci Date: 2019-08-21 Impact factor: 4.077
Authors: Heidi West; Marlar Than; Thinzar Win; Khin Thein Oo; Kyi Khaing; Thin Thin Aye; San Myint Yi; Su Yi Myo; Su Yi Toe; Maja Milkowska-Shibata; Kristin Ringstad; Can Meng; Tomoyuki Shibata Journal: Ann Glob Health Date: 2021-11-11 Impact factor: 2.462
Authors: Ana María Gómez; Luis G Chica; Álvaro F Burbano; Esdras M Vásquez; Jorge A Escobar; Paola M Arias; Dora I Molina Journal: Biomedica Date: 2019-09-01 Impact factor: 0.935